By John Arthur 
Johnson & Johnson continues to face one of the largest mass tort litigations in the United States, with plaintiffs alleging that its talcum powder products, including the iconic Johnson’s Baby Powder, caused ovarian cancer and mesothelioma. As of June 2026, more than 68,000 cases remain pending in the federal multidistrict litigation (MDL) alone, centered in the District of New Jersey.
Recent developments include mixed trial outcomes, with a notable $32 million compensatory verdict in a mesothelioma case in Los Angeles and Johnson & Johnson’s motion to dismiss thousands of ovarian cancer claims in the MDL following the withdrawal of key expert witnesses by some plaintiffs’ attorneys.
This article provides a factual overview of the talcum powder lawsuit, its legal background, current status, and implications for those affected. This article is for informational purposes only and does not constitute legal advice.
Background and Legal Context
Talcum powder lawsuits against Johnson & Johnson stem from allegations that the company’s talc-based products contained asbestos or that talc itself posed cancer risks when used for perineal (genital) application. Plaintiffs claim the company knew of potential risks for decades but failed to warn consumers or reformulate products adequately until shifting to cornstarch-based alternatives in recent years.
The litigation draws on product liability principles under state tort law, including claims of negligence, strict liability for defective design or failure to warn, and, in some cases, breach of warranty. Key scientific debates center on the link between talc use and ovarian cancer (often involving inflammation or potential asbestos contamination) and between asbestos in talc and mesothelioma, a cancer strongly associated with asbestos exposure.
Federal multidistrict litigation (MDL 2738) consolidates pretrial proceedings for efficiency in the U.S. District Court for the District of New Jersey. Parallel cases proceed in state courts, such as those in California, where several high-profile trials have occurred. Johnson & Johnson has maintained that its products are safe and that scientific evidence does not support a causal link in most claims.
The company’s prior attempts to resolve claims through subsidiary bankruptcy filings (often referred to as the “Texas two-step”) were rejected by courts in 2025, returning the cases to the tort system for individual litigation or targeted settlements.
Key Legal Issues Explained
Central to the talcum powder lawsuit are questions of causation and corporate responsibility. Plaintiffs must generally establish general causation (that talc or asbestos in talc can cause the alleged cancers) and specific causation (that the plaintiff’s exposure to the product more likely than not caused their injury). This often relies on expert testimony regarding epidemiology, toxicology, and exposure history, subject to challenges under standards like Daubert in federal courts.
Failure-to-warn claims allege Johnson & Johnson did not adequately disclose risks despite internal documents suggesting awareness of contamination concerns. Mesothelioma cases frequently involve asbestos fiber evidence, while ovarian cancer claims focus more on talc’s potential role in pelvic inflammation or migration of particles.
Johnson & Johnson has prevailed in a majority of ovarian cancer trials tried to verdict over the past decade but has faced significant adverse verdicts in mesothelioma cases. Punitive damages, when awarded, reflect findings of reckless disregard for consumer safety, though appellate courts sometimes reduce or vacate such awards.
Latest Developments and Case Status
As of early June 2026, the federal MDL in New Jersey reports approximately 68,029 pending actions. On or around June 17, 2026, Johnson & Johnson moved to dismiss thousands of ovarian cancer lawsuits in the MDL, arguing that the withdrawal of two key expert witnesses by certain plaintiffs’ counsel undermined the ability to prove causation.
In state court proceedings, a Los Angeles jury awarded $32 million in compensatory damages in mid-June 2026 to the family of a woman who died from mesothelioma after long-term use of Johnson & Johnson baby powder. Earlier in June, a California jury returned a defense verdict in an ovarian cancer bellwether trial.
The first federal bellwether trial has been selected, with proceedings expected to advance. No comprehensive global settlement exists following the rejection of prior bankruptcy proposals. Individual settlements and trial outcomes continue to shape case valuations.
Who Is Affected and Potential Impact
The talcum powder lawsuit primarily affects individuals who used Johnson & Johnson talc-based products, such as baby powder, for personal hygiene over extended periods and later developed ovarian cancer or mesothelioma. Families of deceased users may also pursue wrongful death claims.
Broader impacts extend to consumer product safety standards and corporate accountability in mass torts. Regulatory bodies like the U.S. Food and Drug Administration (FDA) have monitored talc products, with ongoing scrutiny of testing methodologies and contamination risks. Businesses in the personal care industry may face heightened compliance expectations regarding ingredient sourcing and warnings.
Potential outcomes vary: some cases result in defense verdicts or dismissals, while others yield settlements or plaintiff verdicts ranging from millions to, in rare instances, hundreds of millions (subject to reduction on appeal or post-trial motions).
What This Means Going Forward
The rejection of Johnson & Johnson’s bankruptcy strategy has returned focus to traditional litigation, increasing the role of bellwether trials in guiding resolutions. Courts will continue to evaluate expert admissibility, which could influence large groups of cases in the MDL.
For the public, these proceedings highlight the importance of understanding product labels and consulting healthcare providers about potential risks. Stakeholders should monitor developments in the New Jersey MDL, upcoming trials in key jurisdictions like California, and any legislative efforts addressing mass tort resolutions.
The litigation underscores tensions between scientific consensus, regulatory oversight, and judicial determinations of liability under established tort principles.
Frequently Asked Questions
What is the current status of the Johnson & Johnson talcum powder lawsuit? As of June 2026, over 68,000 cases are pending in the federal MDL, with active trials and motions in both federal and state courts. No global settlement is in place.
Can talcum powder cause ovarian cancer or mesothelioma? Plaintiffs allege a link based on studies and exposure evidence, but Johnson & Johnson disputes causation. Courts assess evidence on a case-by-case basis through expert testimony and trial proceedings.
Who qualifies to file a talcum powder lawsuit? Individuals (or their estates) who used Johnson & Johnson talc products and were diagnosed with ovarian cancer or mesothelioma may have claims, subject to statutes of limitations and jurisdictional rules. Consultation with a qualified attorney is necessary to evaluate specific eligibility.
Has Johnson & Johnson settled talcum powder cases? The company has resolved many individual claims and faced prior settlement proposals in bankruptcy proceedings that were not approved. It continues to defend remaining cases vigorously.
What is the MDL process in this litigation? Multidistrict litigation centralizes pretrial proceedings for efficiency while preserving individual trials or settlements. Bellwether cases help gauge strengths for broader resolution.
Are there ongoing trials in 2026? Yes, including bellwether proceedings in federal and state courts, with recent activity in California and preparations for additional trials.
Conclusion
The Johnson & Johnson talcum powder lawsuit represents a significant chapter in product liability law, balancing individual claims for harm against corporate defenses rooted in scientific and regulatory history. With litigation advancing post-bankruptcy rulings, affected parties and observers should stay informed through official court dockets and credible legal sources. Developments in expert rulings, trials, and potential appeals will likely shape outcomes in the months ahead. Readers seeking personalized guidance should consult licensed legal professionals.
Related Topic: OGX Lawsuit Update: Does Your Shampoo Cause Hair Loss?